HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Preclinical and clinical properties of vaniprevir (VANIHEP® Capsules 150 mg), a novel therapeutic agent for hepatitis C].

AuthorsKiyoshi Kinoshita, Takashi Iwasa, Akiko Takase, Keisuke Nakamura
JournalNihon yakurigaku zasshi. Folia pharmacologica Japonica (Nihon Yakurigaku Zasshi) Vol. 146 Issue 3 Pg. 159-70 (Sep 2015) ISSN: 0015-5691 [Print] Japan
PMID26354016 (Publication Type: Journal Article, Review)
Chemical References
  • Antiviral Agents
  • Capsules
  • Cyclopropanes
  • Indoles
  • Isoindoles
  • Lactams, Macrocyclic
  • Sulfonamides
  • Proline
  • vaniprevir
  • Leucine
Topics
  • Antiviral Agents (chemistry, therapeutic use)
  • Capsules (therapeutic use)
  • Clinical Trials as Topic
  • Cyclopropanes
  • Hepacivirus (drug effects, genetics)
  • Hepatitis C (drug therapy)
  • Humans
  • Indoles (chemistry, therapeutic use)
  • Isoindoles
  • Lactams, Macrocyclic
  • Leucine (analogs & derivatives)
  • Proline (analogs & derivatives)
  • Sulfonamides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: